• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Global Breast Cancer Drug Pipeline Capsule - 2012 Product Image

Global Breast Cancer Drug Pipeline Capsule - 2012

  • Published: February 2012
  • Region: Global
  • 17 Pages
  • Fore Pharma

‘Global Breast Cancer Drug Pipeline Capsule – 2012’ is an outline of all the key research and development (R&D) activities of the global Breast Cancer drug market. It covers information on key pipeline molecules in various stages of R&D including all the phases of clinical trials, preclinical research, and drug discovery. The report is up-to-date with full coverage of the licensing activities and partnerships.

This report helps executives to keep a track of their competitors and understand their pipeline molecules. The information presented in this report can be used for identifying the partners, prioritizing, evaluating opportunities, developing business development strategies, and executing in-licensing and out-licensing deals.

The report provides information on pipeline molecules by company and mechanism of action across the different stages of R&D. It includes registered / preregistered stage, phase 3 clinical trial, phase 2 clinical trial, phase 1 clinical trial, preclinical research, and drug discovery. It also provides information on pipeline molecules developed in leading geographies including the U.S., Canada, France, Germany, U.K., READ MORE >

1. Breast Cancer: Disease Definition
2. Breast Cancer Drug Pipeline Overview
3. Breast Cancer Phase 3 Clinical Trial Drug Pipeline Insights
4. Breast Cancer Phase 2 Clinical Trial Drug Pipeline Insights
5. Breast Cancer Phase 1 Clinical Trial Drug Pipeline Insights
6. Breast Cancer Preclinical Research Drug Pipeline Insights
7. Breast Cancer Drug Discovery Pipeline Insights
8. Geographic Landscape of Breast Cancer R&D Activities
8.1. Breast Cancer R&D Activities in North America
8.2. Breast Cancer R&D Activities in Europe
9. Licensing Activities / Partnerships in the Global Breast Cancer Drug Market
10. Research Methodology

List of Tables

Table 1: Breast Cancer Drug Pipeline: Phase 3 Clinical Trial Molecules
Table 2: Breast Cancer Drug Pipeline: Phase 2 Clinical Trial Molecules
Table 3: Breast Cancer Drug Pipeline: Phase 1 Clinical Trial Molecules
Table 4: Breast Cancer Drug Pipeline: Preclinical Research Molecules
Table 5: Breast Cancer R&D Activities by Geography
Table 6: Breast Cancer Drug Pipeline: North America
Table 7: Breast Cancer Drug Pipeline: Europe
Table 8: Breast Cancer Drug Pipeline: Licensing Activities

List of Figures

Figure 1 : Breast Cancer Drug Pipeline Molecules by Stages
Figure 2 : Breast Cancer R&D Activities by Geography

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos